tiprankstipranks
BioStem Technologies (BSEM)
OTHER OTC:BSEM
US Market
BSEM
BioStem Technologies
RESEARCH TOOLSreports
Want to see BSEM full AI Analyst Report?

BioStem Technologies (BSEM) Income Statement

278 Followers

BioStem Technologies Income Statement

Last quarter (Q4 2025), BioStem Technologies's total revenue was $-84.82M, a decrease of -216.94% from the same quarter last year. In Q4, BioStem Technologies's net income was $-11.26M. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 47.48M$ 301.83M$ 16.69M$ 6.88M$ 4.34M
Gross Profit
$ 44.22M$ 287.86M$ 15.42M$ 5.99M$ 2.87M
Operating Expenses
$ 44.91M$ 256.66M$ 23.20M$ 10.67M$ 4.47M
Depreciation and Amortization
$ 219.42K$ 293.22K$ 229.02K$ 243.42K$ 283.90K
EBITDA
$ -469.73K$ 31.49M$ -7.55M$ -6.52M$ -602.00K
Operating Income
$ -689.15K$ 31.20M$ -7.78M$ -4.68M$ -1.61M
Other Income/Expenses
$ 299.50K$ -587.22K$ -704.01K$ -2.55M$ 193.93K
Pretax Income
$ -389.65K$ 30.61M$ -8.48M$ -7.11M$ -1.41M
Net Income
$ -6.58M$ 31.88M$ -8.48M$ -7.07M$ -1.45M
Per Share Metrics
Basic EPS
$ -0.39$ 1.95$ -0.62$ -0.62$ -0.12
Diluted EPS
$ -0.39$ 1.47$ -0.62$ -0.62$ -0.12
Weighted Average Shares Outstanding
 16.73M 16.37M 13.71M 11.41M 11.69M
Weighted Average Shares Outstanding (Diluted)
 16.73M 21.70M 13.71M 11.41M 11.69M
Currency in USD

BioStem Technologies Earnings and Revenue History